New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
20:25 EDTJBLU, JBLU, BSX, BSX, LUV, LUV, HSY, HSY, NBL, NBL, RTN, RTN, PCP, PCP, CELG, CELG, LLY, LLY, BMY, BMY, UNP, UNP, MMM, MMM, CAT, CAT, POT, POT, GM, GM, F, FNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Ford (F), consensus 36c; General Motors (GM), consensus 58c; Potash (POT), consensus 46c; Caterpillar (CAT), consensus $1.52; 3M (MMM), consensus $1.91; Union Pacific (UNP), consensus $1.43; Bristol-Myers Squibb (BMY), consensus 44c; Eli Lilly (LLY), consensus 65c; Celgene (CELG), consensus 89c; Precision Castparts (PCP), consensus $3.35; Raytheon (RTN), consensus $1.59; Noble Energy (NBL), consensus 79c; Hershey (HSY), consensus 76c; Southwest Airlines (LUV), consensus 61c; Boston Scientific (BSX), consensus 19c; JetBlue (JBLU), consensus 19c.
News For F;GM;POT;CAT;MMM;UNP;BMY;LLY;CELG;PCP;RTN;NBL;HSY;LUV;BSX;JBLU From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>
October 21, 2014
07:15 EDTLLY, BMYFDA to hold workshop on breast cancer drug development
Subscribe for More Information
06:26 EDTGMGeneral Motors initiated with a Neutral at Susquehanna
Subscribe for More Information
06:25 EDTFFord initiated with a Neutral at Susquehanna
Subscribe for More Information
October 20, 2014
13:26 EDTCELGCelgene I&I franchise boosted by Crohn’s trial data, says William Blair
William Blair said it views the preliminary Phase II efficacy and safety data from mongersen in Crohn’s disease reported by Celgene as encouraging. The firm noted that the 10 mg arm did not achieve significance, but the three data points collectively formed a robust dose-response that William Blair said lends support for the drug's proposed mechanism of action. William Blair believes mongersen complements Celgene’s Inflammation & Immunology portfolio and the firm maintains its Outperform rating on the stock, which is up 4% to $91.65 in afternoon trading.
13:21 EDTCELGCelgene reports Phase II data in Crohn’s Disease to be presented at UEG
Subscribe for More Information
12:16 EDTUNPCanadian Pacific still interested in consolidation, says UBS
Subscribe for More Information
11:53 EDTGMDeaths tied to faulty GM ignition-switch increases to 29, Reuters says
Subscribe for More Information
09:36 EDTJBLUActive equity options trading on open
Subscribe for More Information
08:22 EDTGMCourt rules GM loan docs valid despite mistake, Reuters reports
Subscribe for More Information
08:16 EDTBSXBoston Scientific initiates PLATINUM Diversity trial
Subscribe for More Information
07:22 EDTMMMSolar Energy Trade Shows to hold a conference
Subscribe for More Information
07:20 EDTBSXInternational Continence Society to hold annual meeting
ICS Annual Meeting 2014 is being held in Rio de Janeiro, Brazil on October 20-24.
07:19 EDTBMYIBC Life Sciences to hold a conference
Subscribe for More Information
07:11 EDTBSXAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
06:09 EDTFFord expected to add over 300 new jobs at Dagenham plant, Guardian reports
Subscribe for More Information
October 17, 2014
18:10 EDTGMGeneral Motors General Counsel Michael Millikin to retire in early 2015
Subscribe for More Information
16:31 EDTGMGeneral Motors announces $12.5B revolving credit facility
Subscribe for More Information
14:39 EDTFFord to hold a conference call
Subscribe for More Information
13:18 EDTCELGLeerink's biotech analyst holds an analyst/industry conference call
Subscribe for More Information
10:51 EDTLLYOptions with increasing implied volatility
Options with increasing implied volatility: COV DISH HLT QEP GREK BKW BYI LLY DTV TIBX
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use